Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer. - Wikidata - awgldk - TriplyDB

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

http://www.wikidata.org/entity/Q37085326

about

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

http://www.wikidata.org/entity/Q37085326

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@en

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@nl

type

label

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@en

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@nl

prefLabel

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@en

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@nl

P1433

Q37085326-C3ECAB29-4FB0-483A-BC8F-328D16ADC4E0

P1476

Q37085326-F59D1370-1BAF-4CF0-B2FF-3EBF9D457EAE

P2093

Q37085326-A2973FDA-CD49-4DB0-B840-C9784929F270

Q37085326-F916D989-4510-44D9-B403-CBDF52D1D062

P2860

Q37085326-0C91404D-DFB2-425A-A96D-904F289D4249

Q37085326-2C0B8CDD-6173-4FDA-83A7-097CF5454391

Q37085326-3F91C086-F4D1-4CB2-B744-37B292B4074A

Q37085326-66AC0733-DF5B-4076-A0F5-1F81C516C410

Q37085326-95629C78-6807-4B33-A2AD-E6427E5E3464

Q37085326-95872391-988F-489C-B081-40BAB2D6B0DD

Q37085326-A91C1757-6BF0-4435-A0B5-D10D05D7E4F3

Q37085326-B48D517B-D0C9-403D-879F-1E403ED9BE23

Q37085326-C1EDC94E-8B67-4C42-9906-9AC51AA269E0

P304

Q37085326-E58490BF-FD61-4CD7-8FBA-54B700844C20

P31

Q37085326-545ECE6E-5650-4155-A5FD-9EA4114607EE

P356

Q37085326-012C308A-F175-4DD8-BE88-785E8A6CC986

P433

Q37085326-59D88DE3-1907-492F-A3FD-BB1DAD3D6DEA

P478

Q37085326-3C6FDD0B-450B-4B1B-95D7-A215830DE93E

P577

Q37085326-A8C71EC9-9907-4E57-8BF2-825ED49B3F7A

P5875

Q37085326-B8468773-7B58-4C00-912D-349E5C207890

P698

Q37085326-EE56E0F4-2358-4072-A069-D8ED35A5BC11

P932

Q37085326-C4617F1E-9E6A-4BE6-BDE8-0F1867BA1CBD

P356

P1433

Asian Journal of Andrology

P1476

Highlights on FOXO3 and tumor-associated dendritic cells in prostate cancer.

@en

P2093

James L Gulley

http://www.w3.org/2001/XMLSchema#string

Kwong Y Tsang

http://www.w3.org/2001/XMLSchema#string

P2860

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.

Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination

Regulatory T cells in ovarian cancer: biology and therapeutic potential.

Promising novel immunotherapies and combinations for prostate cancer

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.

Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.

P304

657-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJA.2011.78

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51231370

http://www.w3.org/2001/XMLSchema#string

P698

21685924

http://www.w3.org/2001/XMLSchema#string

P932

3739599

http://www.w3.org/2001/XMLSchema#string